| Today's Open | $5.43 |
|---|---|
| Previous Close | $5.50 |
| Daily Range | $5.22 - $5.62 |
| 52-Week Range | $2.30 - $6.85 |
| Market Cap | $286.4M |
| P/E Ratio | -6.55 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 187,604 |
| Average Daily Volume | 316,804 |
| Current FY EPS | -$0.85 |
Sector
Healthcare
Industry
Drugs
Sunesis Pharmaceuticals, Inc. (SNSS) Description
The Company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other unmet medical needs. Website: http://www.sunesis.com/
News & Commentary
Sunesis Pharma Loss Narrows in Q4, Widens in 2012
The drugmaker shaves its quarterly loss, but the annual shortfall deepens.Why Sunesis Is Poised to Pull Back
Market-lagging returns could be written in this 1-Star.3 Humongous Health-Care Stocks This Week
The Fool looks at 3 humongous health-care stocks for the past week.SNSS's Top Competitors
(0.91%)
(1.17%)
(-0.80%)
(-0.24%)